Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Recent advances in hair loss treatments show significant progress.

Dutasteride effectively treats hair loss in men who don't respond to finasteride.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Male androgenetic alopecia (MAA) is a common, hereditary hair loss condition in men, linked to heart disease, and can be treated with minoxidil, finasteride, or hair transplantation.

There are several promising treatments for hair loss, including dutasteride, latanoprost, ketoconazole shampoo, anti-androgens, laser/light treatment, and platelet-rich plasma, but more research is needed.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Finasteride effectively treats BPH but requires continuous use to maintain benefits.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Women generally want more hair volume, which becomes a concern around menopause due to hair loss.

Hair loss treatments show limited improvement, sunscreen thickness affects vitamin D production, and the effectiveness of IVIg for toxic epidermal necrolysis is uncertain.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Antiandrogen treatment helps reduce hair follicles and sebaceous glands in hirsute women.

Turkish women with female pattern hair loss have lower hair density, and visual counting is more effective than digital image analysis for detecting this.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

Exercise and finasteride together improve ovary health in PCOS rats.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

PRP injections effectively treat hair loss, with positive results in both monthly and every three months treatments.

The document helps doctors recognize and treat excessive hair growth in women.

Female pattern hair loss negatively affects quality of life, and treatment does not improve it within two months.

Isotretinoin shrinks sebaceous glands without affecting hair or skin color, unlike etretinate.

New treatments for long-lasting erections improve outcomes but must be timely to avoid lasting damage.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

Hirsutism in teen girls is common, usually harmless, but can sometimes signal serious issues and is treatable.

Hormonal therapy in adults with gender dysphoria often leads to skin issues like acne, requiring a team of skin and hormone doctors.

Anti-androgen drugs can help reduce OCD symptoms, but more large-scale trials are needed to confirm their effectiveness.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.